Coverage Initiated on ‘Emerging Antibiotics Growth Story with Multiple Levers for Upside’
September 19, 2018 at 04:00 AM EDT
Source: Streetwise Reports 09/19/2018 An H.C. Wainwright & Co. report outlined the investment thesis for this U.S.-based biopharmaceutical firm. In a Sept. 11 research note, analyst Ed Arce reported that H.C. Wainwright & Co. launched [...]
